DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
Mitochondrial–lysosomal axis in acetaminophen hepatotoxicity
Acetaminophen (APAP) toxicity is the most common cause of acute liver failure and
a major indication for liver transplantion in the United States and Europe. Although
significant progress has been made in understanding the molecular mechanisms
underlying APAP hepatotoxicity, there is still an urgent need to find novel and effective
therapies against APAP-induced acute liver failure. Hepatic APAP metabolism results
in the production of the reactive metabolite N-acetyl-p-benzoquinone imine (NAPQI),
which under physiological conditions is cleared by its conjugation with glutathione
(GSH) to prevent its targeting to mitochondria. APAP overdose or GSH limitation
leads to mitochondrial NAPQI-protein adducts formation, resulting in oxidative stress,
mitochondrial dysfunction, and necrotic cell death. As mitochondria are a major target
of APAP hepatotoxicity, mitochondrial quality control and clearance of dysfunctional
mitochondria through mitophagy, emerges as an important strategy to limit oxidative
stress and the engagement of molecular events leading to cell death. Recent evidence
has indicated a lysosomal–mitochondrial cross-talk that regulates APAP hepatotoxicity.
Moreover, as lysosomal function is essential for mitophagy, impairment in the fusion
of lysosomes with autophagosomes-containing mitochondria may compromise the
clearance of dysfunctional mitochondria, resulting in exacerbated APAP hepatotoxicity.
This review centers on the role of mitochondria in APAP hepatotoxicity and how the
mitochondrial/lysosomal axis can influence APAP-induced liver failure., We acknowledge support from grants SAF2014-57674R, SAF2015-69944R, and SAF2017-85877R from Plan Nacional de
I+D, Spain and by the support of CIBEREHD; the center
grant P50AA011999 Southern California Research Center for
ALPD and Cirrhosis funded by NIAAA/NIH; and support from
AGAUR of the Generalitat de Catalunya SGR-2017-1112 and the
COST ACTION CA17112 Prospective European DILI Network.
AM’s salary is funded through a Ramon y Cajal Fellowship from
the Spanish Government., Peer reviewed
Project:
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 SAF2014-57674-R
,
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 SAF2015-69944-R
,
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 SAF2017-85877-R
View at: http://hdl.handle.net/10261/176492